In the subgroup of the 54 PET-positive patients with a relative reduction of less than 40 % , the risk of progression or relapse within the first year was 23.1 % compared with 5.3 % for patients with a larger reduction ( difference , 17.9 % ; 95 % CI , 5.8 % to 30 % ) .